To investigate the biological function of A2AR in CCM, mice were administered CGS 21680 (a specific agonist of A2AR, 1mg/kg) via intraperitoneal injection to increase the expression of A2AR in the heart (17). Here, ADORA2A is linked to cerebral cavernous malformation.